# Coronary microcirculation dysfunction causing ischemia with non-obstructive coronary arteries: a case report

**Authors:** Wei Qi, Yazheng Zhang, Le Wang, Kai Hou, Ting Li, Jiachun Lang, Hongliang Cong

PMC · DOI: 10.3389/fcvm.2025.1556064 · Frontiers in Cardiovascular Medicine · 2025-04-15

## TL;DR

A case report shows that coronary microcirculation dysfunction can cause heart symptoms even without blocked arteries, and genetic factors like NOTCH1 may be involved.

## Contribution

Identifies a NOTCH1 genetic variant potentially linked to coronary microvascular dysfunction in ischemia with non-obstructive coronary arteries.

## Key findings

- A NOTCH1 c.3862G>A variant was found in a patient with CMVD and INOCA.
- Targeted treatment resolved symptoms and reversed myocardial ischemia.
- The NOTCH1 variant may contribute to CMVD through impaired vascular remodeling.

## Abstract

The study presents a case of INOCA attributed to CMVD in a 53-year-old male patient experiencing exertional angina, despite the absence of significant coronary artery stenosis on angiography. The patient presented with reversible myocardial ischemia detected by myocardial perfusion imaging, with an ischemic area accounting for 12% of the left ventricular wall. Diagnostic tests revealed an elevated index of microcirculatory resistance (IMR = 46.3) and a quantitative flow ratio (QFR = 0.94), confirming CMVD. Genetic testing identified a NOTCH1 c.3862G>A variant in the proband and some family members, suggesting a potential contribution to CMVD pathogenesis through impaired vascular remodeling and microcirculatory regulation. After six months of targeted treatment with nicorandil, coenzyme Q10, trimetazidine, and rosuvastatin, the patient's symptoms resolved, and myocardial ischemia reversed. While an MYH7 variant was also detected, its clinical relevance was ruled out due to the family's absence of associated cardiomyopathy phenotypes. The NOTCH1 gene may play a potential role in INOCA caused by CMVD, however, further research is needed to elucidate its underlying regulatory mechanisms. The findings provide a foundation for precise diagnosis and personalized management of INOCA.

## Linked entities

- **Genes:** NOTCH1 (notch receptor 1) [NCBI Gene 4851], MYH7 (myosin heavy chain 7) [NCBI Gene 4625]
- **Chemicals:** nicorandil (PubChem CID 47528), coenzyme Q10 (PubChem CID 5281915), trimetazidine (PubChem CID 21109), rosuvastatin (PubChem CID 446157)
- **Diseases:** cardiomyopathy (MONDO:0004994)

## Full-text entities

- **Genes:** MYH7 (myosin heavy chain 7) [NCBI Gene 4625] {aka CMD1S, CMH1, CMYO7A, CMYO7B, CMYP7A, CMYP7B}, NOTCH1 (notch receptor 1) [NCBI Gene 4851] {aka AOS5, AOVD1, TAN1, hN1}
- **Diseases:** exertional angina (MESH:C564288), coronary artery stenosis (MESH:D023921), ischemic (MESH:D002545), cardiomyopathy (MESH:D009202), myocardial ischemia (MESH:D017202), ischemia (MESH:D007511)
- **Chemicals:** trimetazidine (MESH:D014292), rosuvastatin (MESH:D000068718), coenzyme Q10 (MESH:C024989), nicorandil (MESH:D020108)
- **Species:** Homo sapiens (human, species) [taxon 9606]
- **Mutations:** c.3862G>A

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12037479/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12037479/full.md

## References

26 references — full list in the complete paper: https://tomesphere.com/paper/PMC12037479/full.md

---
Source: https://tomesphere.com/paper/PMC12037479